Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 297-025-4 | CAS number: 93281-13-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- November from 15 to 22, 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: readings was difficult and in some cases not feasible, due to substance staining
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Version / remarks:
- adopted February 24th, 1987
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- GLP compliance:
- yes
Test material
- Reference substance name:
- Direct Black 168
- IUPAC Name:
- Direct Black 168
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: PI PETIT (El Masnou, Barcelona, Spain).
- Age at study initiation: approximately 14 weeks.
- Weight at study initiation: 2.3 - 2.5 kg.
- Housing: housed individually in stainless steel cages (48 x 59 x 37 cm), with a grille floor, placed on racks.
- Diet: standard rabbit diet UAR 112, ad libitum.
- Water: an automatic drinking system, ad libitum.
- Acclimation period: at least 7 days.
- Health check: both eyes of each animal were examined before treatment in order to reject any animal showing eye alterations.
ENVIRONMENTAL CONDITIONS
- Temperature: 19 ± 2 °C, sometimes reaching 16 and 22 °C.
- Humidity: 40 - 70 %, sometimes reaching levels of 28 - 39 % and 75 - 80 %.
- Photoperiod: 12 hour light/12 hour dark.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- - Amount applied: 0.1 ml
- Application: the test substance was instilled, undiluted, in a single application. - Duration of treatment / exposure:
- 24 hours
- Observation period (in vivo):
- 7 days
- Number of animals or in vitro replicates:
- 3 males
- Details on study design:
- APPLICATION OF TEST MATERIAL
The animal was immobilized and the product was poured into the right conjunctival sac, made perfectly accessible by care fully pulling out the lower lid. After application of the test substance, the lids of the treated eye were held closed for approximately one second.
REMOVAL OF TEST SUBSTANCE
- Washing: the treated eye was washed with 0.9 % w/v sodium chloride solution, after Colirusi Fluoresceina application.
- Time after start of exposure: 24 hours.
TOOL USED TO ASSESS SCORE
Followving the reading carried out 24 hours after treatment, Colirusi Fluoresceina was applied to the treated eye of each animal.
SCORING SYSTEM
The degree of eye irritation was evaluated for each rabbit 1, 24, 48 and 72 hours after treatment, following the guideline.
All the measures carried out at each 24, 48 and 7 hour examination for each type of lesion are used respective mean values.
- Corneal Irritation
Opacity: degree of density (densest area used for assessment)
No ulceration or opacity............................................................................................................................................... 0
Scattered or diffuse areas of opacity (apart from slight loss of normal luster), details of iris clearly visible............. 1
Easily discernible translucent area, details of iris slightly blurred................................................................................2
Opalescent area, details of iris not visible, countour of pupil barely discernible.........................................................3
Opaque cornea, iris not discernible through the opacity............................................................................................. 4
- The area of corneal opacity was recorded according to the following scale:
A quarter or less, but not zero ......................1
More than a quarter, less than half................2
More than half, less than three quarters........3
More than three quarters, up to whole area...4
- Iridic Irritation
Normal............................................................................................................................................................................0
Deeply marked folds, congestion, swelling, moderate hyperemia around corena or injection, one or more
of the aforementioned, iris conserving reaction to light................................................................................................ 1
No reaction to light, hemorrhage, serious damage (any or all of the above)................................................................ 2
- Conjuctival Irritation
Redness (refers to palpebral and bulbar conjunctivae, cornea and iris).
Normal blood vessels................................................................................................................................................... 0
Some clearly hyperemic blood vessels (injected)........................................................................................................ 1
Diffuse, crimson color, individual vessels difficult to discern...................................................................................... 2
Diffuse deep red........................................................................................................................................................... 3
- Edema: lids and/or nictitating membranes
No swelling.................................................................................................................................................................... 0
Some swelling above normal (includes nictitating membranes).....................................................................................1
Obvious swelling with partial eversion of lids............................................................................................................... 2
Swelling wi th lids about half closed............................................................................................................................. 3
Swelling with lids more than half closed....................................................................................................................... 4
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 2/3
- Time point:
- 24/48/72 h
- Score:
- 1
- Reversibility:
- not fully reversible within: 7 days, in one animal
- Irritation parameter:
- iris score
- Basis:
- animal: 3/3
- Time point:
- 24/48/72 h
- Remarks on result:
- not determinable
- Remarks:
- due to the coloring from test substance
- Irritation parameter:
- conjunctivae score
- Basis:
- animal: 1/3
- Time point:
- 24/48/72 h
- Score:
- 2.33
- Reversibility:
- not fully reversible within: 7 days
- Remarks on result:
- not determinable
- Remarks:
- in 2 out of 3 animals
- Irritation parameter:
- chemosis score
- Basis:
- animal: 2/3
- Time point:
- 24/48/72 h
- Score:
- < 2
- Reversibility:
- not fully reversible within: 7 days, in one animal
- Remarks on result:
- other: in the 3rd animal reaction were not recorded within 7 days
- Irritant / corrosive response data:
- In the course of the first 24 hours after administration, all the animals showed edernatic lesions ranging from swelling of the lids (grade 1) to more than half closed lids (grade 4).
Discharge was also observed ranging from light to moistening of the lids and surrounding hair, affecting a considerable area around the eye and injected vessels in the bulbar conjunctivae.
24 hours following administration, all the animals showed diffuse opacity of the cornea (grade 1) ranging from an affected area of one quarter (grade 1) to near totality of the cornea (grade 4). Due to the colouring produced by the test substance in the eyes of the animals, diffused crimson vessels (grade 3) were observed in the palpebral conjunctivae of only one animal and none of the animal's irises could be clearly observed .
2 , 3 and 4 days following administration, observed ocular injuries were seen to be subsiding.
7 days post-administration, one animal showed vessels of the palpebral conjunctivae clearly more injected than normal (grade 1). Also, another animal showed nearly half closed, swollen lids (grade 3) and diffuse opacity of the cornea (grade 1) which occupied less than one quarter of the total area (grade 1). - Other effects:
- CLINICAL SIGNS
The behaviour and physical condition of the rabbits were normal throughout the Study.
Any other information on results incl. tables
The eye irritation scores for each animal are presented in the table below.
Animal N. | Reaciton | 1 h | 24 hrs | 48 hrs | 72 hrs | 4 d | 7 d | Mean 24/48/72 hrs | |
3989 | Cornea | Density | - | 1 | 1 | 1 | 1 | 0 | 1.00 |
Area | - | 4 | 3 | 2 | 1 | 0 | - | ||
Iris | - | - | - | - | - | - | - | ||
Conjunctiva | Hyperemia | - | - | - | - | - | - | - | |
Oedema | 3 | 1 | 1 | 1 | 1 | 0 | 0.33 | ||
4101 | Cornea | Density | - | 1 | 0 | 0 | 0 | 0 | 0.33 |
Area | - | 1 | 0 | 0 | 0 | 0 | - | ||
Iris | - | - | - | - | 0 | 0 | - | ||
Conjunctiva | Hyperemia | - | 3 | 2 | 2 | 2 | 1 | 2.33 | |
Oedema | 2 | 2 | 1 | 1 | 1 | 0 | 1.33 | ||
3993 | Cornea | Density | - | 1 | 1 | 1 | 1 | 1 | 1.00 |
Area | - | 4 | 3 | 2 | 2 | 1 | - | ||
Iris | - | - | - | - | - | - | - | ||
Conjunctiva | Hyperemia | - | - | - | - | - | - | - | |
Oedema | 3 | 4 | 4 | 4 | 4 | 3 | 4.00 |
- : non quantifiable due to the colouring from test substance.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The substance is considered to be an eye irritant to rabbits.
- Executive summary:
The substance was assessed for eye irritation potential to rabbits, according to the OECD guideline 405. The right eye of three male rabbits was treated with the substance (non diluted) and after 24 hours the eyes were washed.
In the course of the first 24 hours after administration, the substance induced edematic lesions, ranging from some swelling above normal of the lids (grade 1) to more than halfclosed lids (grade 4). Also observed were injected vessels in the bulbar conjunctivae of all animals and discharge ranging from mild to moistening of the lids and surrounding hair, affecting a considerable area around the eye. All the animals showed opacity of the cornea (grade 1) ranging from an affected area of one quarter (grade 1) to near totality of the cornea (grade 4). Due to the colouring produced by the test substance in the palpebral conjunctivae and iris of some of the animals, diffused crimson vessels (grade 3) were observed in only one animal. 2, 3 and 4 days following administration, observed ocular injuries had begun to subside.
In the reading carried out 7 days post-administration, one animal showed vessels clearly more injected than normal (grade 1) in the palpebral conjunctivae. Also, another animal showed nearly half closed, swollen lids (grade 3) and opacity of the cornea (grade 1) which occupied less than one quarter of the total area (grade 1).
Conclusion
The substance is considered to be an eye irritant to rabbits.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
